Looks like Sharon Will has been moonlighting. Lets check out Saggi Capital Corp.
April 5, 1999
For More Information Contact:
Sharon Will
Saggi Capital Corp
Tel: 212-572-0762
FAX: 212-572-0764
Internet: Investor.Relations@CRYO-CELL.com
FOR IMMEDIATE RELEASE
CRYO-CELL Achieves Record Growth for its U-Cord? Program
April 5, 1999 - Gerald F. Maass, Executive Vice President & General Manager, announced today that CRYO-CELL International, Inc. achieved a record month in March for each of the business?s key indicators for the company?s umbilical cord (U-Cord?) stem cell preservation program. For the first time, monthly enrollment inquiries through the 1-800-STOR-CELL number, web site and client referrals surpassed the 1000 mark. Cord blood collection kit sales exceeded 400. Our laboratory received, processed and stored in excess of 365 specimens, representing a 52% increase over February. The company believes that the growth in revenues, which began to intensify during fiscal fourth quarter, 1998, has positioned the company well to continue as America?s fastest growing U-Cord stem cell firm.
According to Jill Taymans, the company?s Chief Financial Officer, CRYO-CELL?s sales for the first four months of fiscal 1999 are already exceeding the annual sales of 1998. March invoices exceeded $100,000 for the first time. The company believes it could be profitable within the next 12 months. The combination of local, regional, and national media coverage in conjunction with CRYO-CELL?s own marketing programs are serving to increase the awareness of expectant parents for preserving stem cells.
Steven Ferens, President of Medical Marketing Network (a CRYO-CELL subsidiary) commented, "Our progress to date in gaining the support of OB/GYN physicians for the CRYO-CELL U-Cord Program has exceeded our expectations. During March alone, nearly 450 additional physicians have indicated their support for the CRYO-CELL mission of affordable stem cell storage and have requested the company?s materials to distribute to their patients." In less than three months, Medical Marketing Network has personally contacted over 700 OB/GYNs. These can be added to the more than 2000 physicians who have already provided their services to support their patients? decision to preserve their newborn?s U-Cord stem cells. Physician support, coupled with expectant parent awareness, are the keys to unlocking the market potential of over 4 million annual births.
According to Daniel D. Richard, President & Chief Executive Officer, "I couldn?t be more pleased with the positive March results. Our investments in our promotional campaigns with Lamaze Publishing, Inc., our acquisition of Medical Marketing Network, and the continual enhancement of our own web site (www.CRYO-CELL.com) are all contributing to our rapid growth." The company?s new two minute video segment on the Lamaze 1999 You and Your Baby tutorial tape will be released by the end of April to over 12,000 childbirth educators for viewing by a projected 1.8 million expectant parents. The company?s full page advertisements also appear in each issue of Lamaze Parents (distribution of 2.4 million expectant mothers in their third trimester) and Lamaze para Padres, Spanish translated magazine (to be distributed to 450,000 Hispanic mothers-to-be). Other marketing programs, including the completion of an info-medical, are in progress. Each of these programs is serving to heighten the awareness that expectant parents have an affordable alternative to discarding their newborn?s cord blood by preserving the stem cells for their family?s potential future use without the need to pay as much as $1500 for this service.
CRYO-CELL offers America?s most affordable cord blood stem cell processing and storage service. The initial fee of $275 includes the specimen collection kit, processing, testing and first year?s storage. The annual storage fee thereafter is fixed at $50 for specimens already stored. The company will publish its first quarter (ending 2/99) financials by 4/14/99.
CRYO-CELL?s common stock trades on The NASDAQ Stock Market© under the symbol ? C C E L.
Forward Looking Statements
Statements wherein the terms "believes", "intends", or "expects" as used are intended to reflect "forward looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward looking statements or paragraphs. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K filed by the Company.
For More Information Contact:
Sharon Will
Saggi Capital Corp
Tel: 212-572-0762
FAX: 212-572-0764
Internet: Investor.Relations@CRYO-CELL.com
|
